Back to top
Bonmax pth autopen
Bonmax pth autopen

Bonmax pth autopen

Bonmax pth autopen Specification

  • Salt Composition
  • Recombinant Human Parathyroid Hormone (rhPTH)
  • Pacakaging (Quantity Per Box)
  • 1 unit per box
  • Origin of Medicine
  • Biotechnologically-derived medication
  • Drug Type
  • Parathyroid Hormone Analog
  • Ingredients
  • Parathyroid Hormone (PTH)
  • Physical Form
  • Injection Pen
  • Function
  • Treatment of Osteoporosis
  • Recommended For
  • Postmenopausal women and men at high risk of fractures
  • Dosage
  • Determined by healthcare provider based on patient needs
  • Dosage Guidelines
  • Administered subcutaneously once daily as recommended by a healthcare provider
  • Suitable For
  • Adults at risk of osteoporosis or bone fractures
  • Quantity
  • 1 Autopen (including refill cartridges if applicable)
  • Storage Instructions
  • Store in a refrigerator at 2-8C. Do not freeze. Protect from light.
 
 

About Bonmax pth autopen



Bonmax pth autopen is a revolutionary product containing Recombinant Human Parathyroid Hormone (rhPTH) designed as an effective Parathyroid Hormone Analog for treating osteoporosis in adults, especially in postmenopausal women and men at high risk of fractures. This injection pen comes in a single unit packaging with the option of refill cartridges if needed. Administered subcutaneously once daily according to dosage guidelines set by healthcare providers, this medication is biotechnologically-derived and should be stored in a refrigerator at 2-8C.

FAQs of Bonmax pth autopen:


Q: What is the recommended usage of Bonmax pth autopen?

A: Bonmax pth autopen is to be administered subcutaneously once daily as prescribed by your healthcare provider.

Q: Who is Bonmax pth autopen suitable for?

A: Bonmax pth autopen is suitable for adults at risk of osteoporosis or bone fractures, particularly postmenopausal women and men at higher risk.

Q: How should Bonmax pth autopen be stored?

A: Bonmax pth autopen should be stored in a refrigerator at 2-8C, ensuring it is not frozen and protected from light exposure.

Q: How is the dosage of Bonmax pth autopen determined?

A: The dosage of Bonmax pth autopen is determined by healthcare providers based on individual patient needs.

Q: What is the origin of Bonmax pth autopen medication?

A: Bonmax pth autopen is a biotechnologically-derived medication designed to treat osteoporosis effectively.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Osteoporsis Category

Idrofos 6 mg Injection

Idrofos 6 mg Injection

Pacakaging (Quantity Per Box) : 1 vial per box

Salt Composition : Ibandronic Acid 6 mg

Physical Form : Liquid

Recommended For : Individuals with osteoporosis cancer patients with bone metastases

Ingredients : Ibandronic Acid

Function : Treatment of osteoporosis and prevention of bonerelated complications in cancer patients, Other

Bonebay 60 mg Tablet

Bonebay 60 mg Tablet

Pacakaging (Quantity Per Box) : 10 strips per box

Salt Composition : Ibandronic Acid

Physical Form : Tablet, Other

Recommended For : Patients with osteoporosis or bonerelated disorders

Ingredients : Ibandronic Acid 60 mg

Function : Other, Used to treat osteoporosis and promote bone health

Gemtide 600 mcg Injection

Gemtide 600 mcg Injection

Pacakaging (Quantity Per Box) : 1 vial per box

Salt Composition : Gemcitabine Hydrochloride

Physical Form : Liquid

Recommended For : Cancer treatment (e.g. pancreatic cancer breast cancer ovarian cancer and nonsmall cell lung cancer)

Ingredients : Gemcitabine Hydrochloride

Function : Chemotherapy drug used to treat various types of cancer, Other

Terifrac 3 ml Cartridge 3N

Terifrac 3 ml Cartridge 3N

Pacakaging (Quantity Per Box) : 3 cartridges per box

Salt Composition : Teriparatide acetate

Physical Form : Liquid

Recommended For : Patients with osteoporosis or severe bone loss

Ingredients : Teriparatide

Function : Other, Boneforming agent; used for the treatment of osteoporosis